With the board changes and low share price, we might see former shareholders coming back to their positions again. Risks still remain though.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025